Artelo Biosciences, Inc. (ARTL) vs NewcelX Ltd. (NCEL)
A side-by-side comparison of Artelo Biosciences, Inc. and NewcelX Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARTL
Artelo Biosciences, Inc.
$3.44HealthcareDelayed quote: Oct 6, 2026, 3:18 PM EDT
NCEL
NewcelX Ltd.
$2.96HealthcareDelayed quote: Oct 6, 2026, 3:13 PM EDT
Total return — ARTL vs NCEL
growth of $100 · dividends reinvested · last 6yARTL -99.5% (-58.9%/yr)NCEL -99.8% (-63.2%/yr)ARTL compounded faster over this window
ARTL NCEL
ARTL vs NCEL: by the numbers
- •NCEL is the larger company ($1M vs $1M market cap).
Metrics side by side
Valuation
| Metric | ARTL | NCEL |
|---|---|---|
| P/B ratio | 0.27 | 0.22 |
Profitability
| Metric | ARTL | NCEL |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -253.57% | -114.48% |
| ROIC | -219.36% | -32.53% |
Growth (annualized)
| Metric | ARTL | NCEL |
|---|---|---|
| Total return CAGR (5Y) | -64.27% | -68.96% |
Frequently asked
- How have ARTL and NCEL total returns compared?
- Over the past 5 years, ARTL delivered -64.27% and NCEL delivered -68.96% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.